ANDRES MANUEL R
CERVANTES RUIPEREZ
CATEDRÁTICO/A DE UNIVERSIDAD
Christie Hospital NHS Foundation Trust
Mánchester, Reino UnidoPublications in collaboration with researchers from Christie Hospital NHS Foundation Trust (8)
2023
-
In the literature: September 2023
ESMO Open
-
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
ESMO Open, Vol. 8, Núm. 3
-
Young oncologists’ perspective on the role and future of the clinician-scientist in oncology
ESMO Open
2016
2015
-
Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer
Clinical Cancer Research, Vol. 21, Núm. 24, pp. 5469-5479
2014
-
Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer
Annals of Oncology, Vol. 25, Núm. 1, pp. 107-116
-
The current and future role of the medical oncologist in the professional care for cancer patients: A position paper by the European Society for Medical Oncology (ESMO)
Annals of Oncology, Vol. 25, Núm. 1, pp. 9-15
2004
-
A phase IIA study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f), administered at two different dose schedules in patients with platinum- and taxane-resistant/refractory ovarian cancer
Gynecologic Oncology, Vol. 95, Núm. 1, pp. 114-119